News

Large Study Finds IV Iron Treatment During Pregnancy Safe and Effective for Anemia

Media Contact:Karen Addis, APRkaren@addispr.com+1 (301) 787-2394 One of the Largest Studies of its Kind Finds Early Intervention with Iron Delivered Intravenously During Pregnancy is a Safe and Effective Treatment for Anemia Denver, Colo. ― Anemia during pregnancy is a common occurrence and... Continue Reading

Large Study Finds Maternal Biomarker Test Reduces Neonatal Morbidities and Improves Outcomes

Media Contact:Karen Addis, APRkaren@addispr.com+1 (301) 787-2394 One of the Largest Studies on Preterm Birth Finds a Maternal Biomarker Test Significantly Reduces Neonatal Morbidities and Improves Neonatal Outcomes Denver, Colo. ― Preterm birth ― defined as delivery before the 37th week of... Continue Reading

New Study Finds Increased Maternal Complications with Previable Premature Rupture of Membranes

FOR IMMEDIATE RELEASE:Jan. 30, 2025 Media Contact:Karen Addis, APRkaren@addispr.com+1 (301) 787-2394 New Study Finds Increased Maternal Complications with Previable Premature Rupture of Membranes Denver, Colo. ― Previable premature rupture of membranes (PROM) is when the amniotic sac, the... Continue Reading

New Study Highlights AI’s Potential to Help Doctors Detect Congenital Heart Defects

Media Contact:Karen Addis, APRkaren@addispr.com+1 (301) 787-2394 New Study Highlights AI’s Potential to Help Doctors Detect Congenital Heart Defects Denver, Colo. ― Congenital heart defects (abnormalities of the heart that are present at birth) are the most common type of birth defect and,... Continue Reading

New National Study Finds Homicide and Suicide is the #1 Cause of Maternal Death in the U.S.

Media Contact:Karen Addis, APRkaren@addispr.com+1 (301) 787-2394 New National Study Finds Homicide and Suicide is the #1 Cause of Maternal Death in the U.S. Denver, Colo. ― In the medical community, research has traditionally focused on how to prevent and treat the leading medical causes of... Continue Reading

New Study Finds High Concentrations of Plastics in the Placentae of Infants Born Prematurely

Media Contact:Karen Addis, APRkaren@addispr.com+1 (301) 787-2394 New Study Finds High Concentrations of Plastics in the Placentae of Infants Born Prematurely Denver, Colo. ― Microplastics, which are less than 5 millimeters, and nanoplastics, which are invisible to the naked eye, are widespread... Continue Reading

SMFM Announces Cooperative Agreement with CDC

Washington, DC—The Society for Maternal-Fetal Medicine (SMFM) has received a multiyear award totaling more than $1.3 million from the Centers for Disease Control and Prevention (CDC) to build capacity and collaboration among maternal health professional organizations and to improve care... Continue Reading

Announcing the Editor-In-Chief of Pregnancy, the official journal of the SMFM

On behalf of the Society’s Board of Directors, I am pleased to announce the appointment of William A. Grobman, MD, MBA, as Editor-In-Chief of Pregnancy. Effective September 1, Dr. Grobman will oversee the solicitation, submission, evaluation, peer-review, and selection of scientific and... Continue Reading

SMFM Statement on Supreme Court Ruling on Emergency Abortion Care

Today, the U.S. Supreme Court issued its ruling in an Idaho case concerning the Emergency Medical Treatment and Labor Act (EMTALA) — a federal law that requires hospitals to treat and stabilize anyone who presents with an emergency medical condition. While the Court did not rule on the... Continue Reading

Leading Medical Organizations Call for the FDA to Permanently Remove Restrictions on Mifepristone

The following statement is issued jointly by the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists, the American College of Preventive Medicine, the American Medical Association, the American Society for Reproductive Medicine, the American Urogynecologic... Continue Reading

SMFM Statement on Supreme Court Decision to Uphold Access to Medication Abortion

The Supreme Court’s ruling yesterday ensures that mifepristone, a critical medication for reproductive health and abortion care, remains available to patients and that clinicians can continue to provide evidence-based care without additional undue restrictions. “This decision is a... Continue Reading

Clinicians Urge the Supreme Court to Protect Access to Mifepristone

On March 26, 2024, the Supreme Court of the United States will hear oral arguments in Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration, a case in which anti-abortion activists are continuing their ongoing attacks on abortion and other reproductive health care by challenging... Continue Reading